XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:      
Net income $ 37 $ 2 $ 126
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 133 272 285
Deferred income taxes   118 (242)
Government and other legal settlements and related costs     4
Stock-based compensation expense 5 13 5
Impairment and (gain) loss on sale of businesses, net 2 23 56
Loss from early extinguishment of debt 8 79 4
Other non-cash expenses, net   (3) 73
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:      
Patient accounts receivable   (32) 313
Supplies, prepaid expenses and other current assets   31 21
Medicare accelerated payments     1,158
Repayment/derecognition of Medicare accelerated payments   (134)  
Pandemic relief funds     116
Accounts payable, accrued liabilities and income taxes   (2) (160)
Other   (87) (49)
Net cash provided by operating activities   280 1,710
Cash flows from investing activities:      
Acquisitions of facilities and other related businesses   (4)  
Purchases of property and equipment   (212) (192)
Proceeds from disposition of hospitals and other ancillary operations   7 152
Proceeds from sale of property and equipment   3 2
Purchases of available-for-sale debt securities and equity securities   (63) (39)
Proceeds from sales of available-for-sale debt securities and equity securities   48 43
Increase in other investments   (34) (19)
Net cash used in investing activities   (255) (53)
Cash flows from financing activities:      
Repurchase of restricted stock shares for payroll tax withholding requirements   (5) (1)
Deferred financing costs and other debt-related costs   (310) (32)
Redemption of noncontrolling investments in joint ventures   (3) (2)
Distributions to noncontrolling investors in joint ventures   (66) (57)
Proceeds from sale-lease back     2
Other borrowings   19 31
Issuance of long-term debt   4,310 1,462
Proceeds from ABL Facility     540
Repayments of long-term indebtedness   (4,396) (2,264)
Net cash used in financing activities   (451) (321)
Net change in cash and cash equivalents   (426) 1,336
Cash and cash equivalents at beginning of period   1,676 216
Cash and cash equivalents at end of period 1,250 1,250 1,552
Supplemental disclosure of cash flow information:      
Interest payments (101) (304) (486)
Income tax (payments) refunds, net $ (1) $ (1) $ 2